Surface modified liposomes for nasal delivery of DNA vaccine
- 17 March 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (18), 2225-2233
- https://doi.org/10.1016/j.vaccine.2008.02.058
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cationic transfersomes based topical genetic vaccine against hepatitis BInternational Journal of Pharmaceutics, 2007
- Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccineBiochemical and Biophysical Research Communications, 2004
- Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in miceBiochemical and Biophysical Research Communications, 2004
- Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1Vaccine, 2003
- Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180Comparative Immunology, Microbiology and Infectious Diseases, 2003
- Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunizationHepatology, 2003
- DNA VACCINESAnnual Review of Immunology, 1997
- High Yield Incorporation of Plasmid DNA within Liposomes: Effect on DNA Integrity and Transfection EfficiencyJournal of Drug Targeting, 1996
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Hepatitis B VaccineNew England Journal of Medicine, 1980